Related references
Note: Only part of the references are listed.Metastatic dissemination patterns of different primary tumors to the spine and other bones
Julia S. Onken et al.
CLINICAL & EXPERIMENTAL METASTASIS (2019)
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study
Olivia Le Saux et al.
EUROPEAN JOURNAL OF CANCER (2019)
Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter Study
Jun Yamamura et al.
IN VIVO (2019)
Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases
N. C. Turner et al.
ANNALS OF ONCOLOGY (2018)
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2018)
Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer A Single Institution Experience
Bianca Rogoz et al.
CLINICAL BREAST CANCER (2018)
Clinical pattern of primary systemic therapy and outcomes of estrogen receptor-positive, HER2-negative metastatic breast cancer: a review of a single institution
Junichiro Watanabe et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis
Marta Bonotto et al.
BREAST (2017)
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
Lowell E. Schnipper et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Impact of breast cancer subtypes and patterns of metastasis on outcome
Karin Kast et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Trends in survival for patients with metastatic breast cancer: is survival improving?
Jacopo Giuliani et al.
TUMORI (2015)
Management of patients with hormone receptor-positive breast cancer with visceral disease: challenges and treatment options
Wael A. Harb
CANCER MANAGEMENT AND RESEARCH (2015)
Trends in survival for patients with metastatic breast cancer: is survival improving?
Jacopo Giuliani et al.
TUMORI (2015)
Clinical outcomes among HR+/HER2-metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US
Jipan Xie et al.
EXPERIMENTAL HEMATOLGY & ONCOLOGY (2015)
Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites
Paul K. Newton et al.
NPJ BREAST CANCER (2015)
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients
A. C. Regierer et al.
ANNALS OF ONCOLOGY (2014)
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial
Antonio Llombart-Cussac et al.
BREAST (2014)
Prognostic factors for survival in metastatic breast cancer by hormone receptor status
A. B. G. Kwast et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution
Wakako Tsuji et al.
BREAST CANCER (2014)
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
Dorien J. A. Lobbezoo et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Factors associated with mortality after breast cancer metastasis
Su Yon Jung et al.
CANCER CAUSES & CONTROL (2012)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic factors in 1038 women with metastatic breast cancer
R. Largillier et al.
ANNALS OF ONCOLOGY (2008)
Breast cancer with synchronous metastases: Trends in survival during a 14-year period
F Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Is breast cancer survival improving? Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000
SH Giordano et al.
CANCER (2004)
Patterns of relapse and modalities of treatment of breast cancer: The 'IRIS' project, a multicenter observational study
M Cazzaniga et al.
ONCOLOGY (2004)
Prognostic factors for patients with hepatic metastases from breast cancer
L Wyld et al.
BRITISH JOURNAL OF CANCER (2003)
Goals and objectives in the management of metastatic breast cancer
CT Chung et al.
ONCOLOGIST (2003)
Share Paper
